For example, the aberrant expression of FN can activate cellular signaling pathways, such as PI3K/Akt, ERK, and FAK signaling, through interaction with tumor cell α5β1 or β1 integrins, which leads to tumor cell resistance to chemotherapeutic agents [126]. This evidence concerns the gene AKT1 and neoplasm.